284 related articles for article (PubMed ID: 32066666)
1. Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios.
Zhang L; Huang CC; Dai Y; Luo Q; Ji Y; Wang K; Deng S; Yu J; Xu M; Du X; Tang Y; Shen C; Feng J; Sahakian BJ; Lin CP; Li F
Transl Psychiatry; 2020 Jan; 10(1):9. PubMed ID: 32066666
[TBL] [Abstract][Full Text] [Related]
2. Improved symptoms following bumetanide treatment in children aged 3-6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial.
Dai Y; Zhang L; Yu J; Zhou X; He H; Ji Y; Wang K; Du X; Liu X; Tang Y; Deng S; Langley C; Li WG; Zhang J; Feng J; Sahakian BJ; Luo Q; Li F
Sci Bull (Beijing); 2021 Aug; 66(15):1591-1598. PubMed ID: 36654288
[TBL] [Abstract][Full Text] [Related]
3. Bumetanide, a Diuretic That Can Help Children with Autism Spectrum Disorder.
Shaker E; El Agami O; Salamah A
CNS Neurol Disord Drug Targets; 2024; 23(4):536-542. PubMed ID: 37021422
[TBL] [Abstract][Full Text] [Related]
4. Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy.
Pretzsch CM; Voinescu B; Lythgoe D; Horder J; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Edden RAE; Williams S; Murphy DGM; Daly E; McAlonan GM
Transl Psychiatry; 2019 Nov; 9(1):313. PubMed ID: 31748505
[TBL] [Abstract][Full Text] [Related]
5. Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.
Lemonnier E; Villeneuve N; Sonie S; Serret S; Rosier A; Roue M; Brosset P; Viellard M; Bernoux D; Rondeau S; Thummler S; Ravel D; Ben-Ari Y
Transl Psychiatry; 2017 Mar; 7(3):e1056. PubMed ID: 28291262
[TBL] [Abstract][Full Text] [Related]
6. The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder.
Li Q; Zhang L; Shan H; Yu J; Dai Y; He H; Li WG; Langley C; Sahakian BJ; Yao Y; Luo Q; Li F
Transl Psychiatry; 2022 Jun; 12(1):228. PubMed ID: 35660740
[TBL] [Abstract][Full Text] [Related]
7. A Magnetic Resonance Spectroscopy Study of Superior Visual Search Abilities in Children with Autism Spectrum Disorder.
Edmondson DA; Xia P; McNally Keehn R; Dydak U; Keehn B
Autism Res; 2020 Apr; 13(4):550-562. PubMed ID: 31909886
[TBL] [Abstract][Full Text] [Related]
8. Increased prefrontal GABA concentrations in adults with autism spectrum disorders.
Maier S; Düppers AL; Runge K; Dacko M; Lange T; Fangmeier T; Riedel A; Ebert D; Endres D; Domschke K; Perlov E; Nickel K; Tebartz van Elst L
Autism Res; 2022 Jul; 15(7):1222-1236. PubMed ID: 35587691
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of Cortical GABA and Glutamate in Young Adults With Autism Spectrum Disorder.
Kolodny T; Schallmo MP; Gerdts J; Edden RAE; Bernier RA; Murray SO
Autism Res; 2020 Jul; 13(7):1111-1129. PubMed ID: 32297709
[TBL] [Abstract][Full Text] [Related]
10. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder.
Pretzsch CM; Freyberg J; Voinescu B; Lythgoe D; Horder J; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Edden RAE; Williams S; Murphy DGM; Daly E; McAlonan GM
Neuropsychopharmacology; 2019 Jul; 44(8):1398-1405. PubMed ID: 30758329
[TBL] [Abstract][Full Text] [Related]
11. Region-specific elevations of glutamate + glutamine correlate with the sensory symptoms of autism spectrum disorders.
He JL; Oeltzschner G; Mikkelsen M; Deronda A; Harris AD; Crocetti D; Wodka EL; Mostofsky SH; Edden RAE; Puts NAJ
Transl Psychiatry; 2021 Jul; 11(1):411. PubMed ID: 34326312
[TBL] [Abstract][Full Text] [Related]
12. Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder.
Al-Otaish H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; Urbina MA; El-Ansary A
Metab Brain Dis; 2018 Jun; 33(3):843-854. PubMed ID: 29397522
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of bumetanide in the treatment of autism in children.
Lemonnier E; Degrez C; Phelep M; Tyzio R; Josse F; Grandgeorge M; Hadjikhani N; Ben-Ari Y
Transl Psychiatry; 2012 Dec; 2(12):e202. PubMed ID: 23233021
[TBL] [Abstract][Full Text] [Related]
14. GABA and Glx predict EEG responses of visual sensitivity in autism.
Sapey-Triomphe LA; Puts NAJ; Costa TL; Wagemans J
Autism Res; 2024 May; 17(5):917-922. PubMed ID: 38576253
[TBL] [Abstract][Full Text] [Related]
15. Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial.
Sprengers JJ; van Andel DM; Zuithoff NPA; Keijzer-Veen MG; Schulp AJA; Scheepers FE; Lilien MR; Oranje B; Bruining H
J Am Acad Child Adolesc Psychiatry; 2021 Jul; 60(7):865-876. PubMed ID: 32730977
[TBL] [Abstract][Full Text] [Related]
16. A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism.
Du L; Shan L; Wang B; Li H; Xu Z; Staal WG; Jia F
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):585-8. PubMed ID: 26258842
[TBL] [Abstract][Full Text] [Related]
17. Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials.
James BJ; Gales MA; Gales BJ
Ann Pharmacother; 2019 May; 53(5):537-544. PubMed ID: 30501497
[TBL] [Abstract][Full Text] [Related]
18. Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.
Fuentes J; Parellada M; Georgoula C; Oliveira G; Marret S; Crutel V; Albarran C; Lambert E; Pénélaud PF; Ravel D; Ben Ari Y
Autism Res; 2023 Oct; 16(10):2021-2034. PubMed ID: 37794745
[TBL] [Abstract][Full Text] [Related]
19. Age-related parietal GABA alterations in children with autism spectrum disorder.
DeMayo MM; Harris AD; Song YJC; Pokorski I; Thapa R; Patel S; Ambarchi Z; Thomas EE; Hickie IB; Guastella AJ
Autism Res; 2021 May; 14(5):859-872. PubMed ID: 33634588
[TBL] [Abstract][Full Text] [Related]
20. The association of excitation and inhibition signaling with the relative symptom expression of autism and psychosis-proneness: Implications for psychopharmacology.
Ford TC; Abu-Akel A; Crewther DP
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():235-242. PubMed ID: 30075170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
